Our study reveals a novel regulatory network in glioblastoma cells that enhances our understanding of the pathogenesis of glioblastoma and identifies HOXA10-AS as a potential new therapeutic target for glioblastoma treatment. This evidence concerns the gene HOXA10 and glioblastoma.